» Go to news main
Molly Appeal paves the way to precision cancer treatment
A group of Dalhousie Medical School researchers is spearheading a new initiative to develop personalized cancer treatments, with support from Dalhousie Medical Research Foundation’s 2017-18 Molly Appeal.
“Every person’s cancer is as unique as their fingerprints,” says Dr. Paola Marignani, an internationally known cancer researcher and professor in Dalhousie’s Department of Biochemistry & Molecular Biology who’s leading this year’s Molly Appeal research initiative.
Read more on Dal News.
- CIHR awards Dalhousie researcher for work in metabolic interventions to prevent neonatal sepsis
- Diana’s golden ticket: Dal’s newest Rhodes Scholar is Oxford‑bound on a life‑changing opportunity
- Dalhousie Medical School offers innovative leadership elective to residents
- Dalhousie discovery unravels a mystery of viruses under the sea
- Research in Medicine (RIM) program celebrates 10‑years
- Saunders Matthey Cancer Prevention Foundation: A critical resource to advance cancer research
- Inspiring future health leaders and innovators
- Dal researchers design powerful tech to help fight deadly cancer